Prognosis of metastatic castration-resistant prostate cancer in response to chemotherapy and PSMA expression in circulating tumor cells

被引：0
|
作者：
Nagaya, N. [1 ]
Nagata, M. [1 ]
Ashizawa, T. [1 ]
Lu, Y. [1 ]
Fujita, K. [1 ]
Horie, S. [1 ]
机构：
[1] Juntendo Univ, Urol, Grad Sch Med, Bunkyo ku, Tokyo, Japan
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.10.401
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
275P
引用
收藏
页码：S1579 / S1580
页数：2
相关论文
共 50 条
  • [21] The use of circulating tumor cells in guiding treatment decisions for patients with metastatic castration-resistant prostate cancer
    Onstenk, Wendy
    de Kiaver, Willemijn
    de Wit, Ronald
    Lolkema, Martijn
    Foekens, John
    Sleijfer, Stefan
    CANCER TREATMENT REVIEWS, 2016, 46 : 42 - 50
  • [22] Lu-PSMA-617 for metastatic castration-resistant Prostate Cancer
    Lorenz, Judith
    AKTUELLE UROLOGIE, 2022, 53 (02) : 106 - 106
  • [23] Transcriptome Profiling of Circulating Tumor Cells to Predict Clinical Outcomes in Metastatic Castration-Resistant Prostate Cancer
    Groen, Levi
    Kloots, Iris
    Englert, David
    Seto, Kelly
    Estafanos, Lana
    Smith, Paul
    Verhaegh, Gerald W.
    Mehra, Niven
    Schalken, Jack A.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (10)
  • [24] Association of Circulating Tumor Cells with Inflammatory and Biomarkers in the Blood of Patients with Metastatic Castration-Resistant Prostate Cancer
    Theil, Gerit
    Lindner, Carlotta
    Bialek, Joanna
    Fornara, Paolo
    LIFE-BASEL, 2021, 11 (07):
  • [25] Use of PSMA PET in metastatic castration-resistant prostate cancer (mCRPC)
    Karunaratna, Nathasha
    Jensen, Andrew
    Wong, Shirley
    Shapiro, Julia
    Weickhardt, Andrew
    Spain, Lavinia
    Azad, Arun
    Kwan, Edmond M.
    Muthusamy, Arun
    Torres, Javier
    Parente, Phillip
    Parnis, Francis
    Goh, Jeffrey
    Gibbs, Peter
    Tran, Ben
    Anton, Angelyn
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2020, 16 : 58 - 58
  • [26] PSMA-Targeted Radiotherapy in Metastatic Castration-Resistant Prostate Cancer
    Sartor, A. Oliver
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2021, 19 (08) : 494 - 496
  • [27] FDG and PSMA PET in metastatic castration-resistant prostate cancer (mCRPC)
    Zukotynski, Katherine A.
    Jadvar, Hossein
    Cho, Steve Y.
    Kim, Chun Ki
    Cline, Kathryn
    Emmenegger, Urban
    Hotte, Sebastien J.
    Pond, Gregory Russell
    Winquist, Eric
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [28] Predictive biomarkers in circulating tumor cells to direct management metastatic castration-resistant prostate cancer (mCRPC)
    Scher, Howard I.
    Schonhoft, Joseph
    Dittamore, Ryan
    CANCER RESEARCH, 2019, 79 (13)
  • [29] Circulating Tumor Cells Predict Survival Benefit from Treatment in Metastatic Castration-Resistant Prostate Cancer
    de Bono, Johann S.
    Scher, Howard I.
    Montgomery, R. Bruce
    Parker, Christopher
    Miller, M. Craig
    Tissing, Henk
    Doyle, Gerald V.
    Terstappen, Leon W. W. M.
    Pienta, Kenneth J.
    Raghavan, Derek
    CLINICAL CANCER RESEARCH, 2008, 14 (19) : 6302 - 6309
  • [30] Circulating Tumor Cells as a Biomarker Predictive of Sensitivity to Docetaxel Chemotherapy in Patients with Castration-resistant Prostate Cancer
    Okegawa, Takatsugu
    Itaya, Naoshi
    Hara, Hidehiko
    Tambo, Mitsuhiro
    Nutahara, Kikuo
    ANTICANCER RESEARCH, 2014, 34 (11) : 6705 - 6710
12345